Revenue from operations stood at Rs 2005 crore in Q2: Torrent Pharma
Consolidated revenue from operations stood at Rs 2,005 crore for the quarter under consideration as against Rs 1,894 crore for the same period last year, Torrent Pharma said.
New Delhi: Drug firm Torrent Pharmaceuticals NSE -1.35 % on Wednesday reported a 36.31 per cent rise in consolidated net profit to Rs 244 crore for the September ended quarter on robust sales in the domestic market.
The company had posted a net profit of Rs 179 crore for the corresponding period of the previous fiscal, Torrent Pharmaceuticals said in a BSE filing.
Also Read: Torrent Pharma Q1 net profit up 33 per cent to Rs 216 crore
Consolidated revenue from operations stood at Rs 2,005 crore for the quarter under consideration as against Rs 1,894 crore for the same period last year.
The company's revenue from India business stood at Rs 899 crore for the September quarter as against Rs 815 crore in the year-ago period.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd